179 related articles for article (PubMed ID: 32251338)
1. Organotypic culture as a research and preclinical model to study uterine leiomyomas.
Salas A; López J; Reyes R; Évora C; de Oca FM; Báez D; Delgado A; Almeida TA
Sci Rep; 2020 Mar; 10(1):5212. PubMed ID: 32251338
[TBL] [Abstract][Full Text] [Related]
2. Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities.
Asano R; Asai-Sato M; Matsukuma S; Mizushima T; Taguri M; Yoshihara M; Inada M; Fukui A; Suzuki Y; Miyagi Y; Miyagi E
Fertil Steril; 2019 Jan; 111(1):178-185. PubMed ID: 30554729
[TBL] [Abstract][Full Text] [Related]
3. Hormones and pathogenesis of uterine fibroids.
Reis FM; Bloise E; Ortiga-Carvalho TM
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():13-24. PubMed ID: 26725037
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
Malik M; Britten J; Cox J; Patel A; Catherino WH
Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
[TBL] [Abstract][Full Text] [Related]
5. Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures.
Severino MF; Murray MJ; Brandon DD; Clinton GM; Burry KA; Novy MJ
Mol Hum Reprod; 1996 Nov; 2(11):823-8. PubMed ID: 9237221
[TBL] [Abstract][Full Text] [Related]
6. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
Sant'Anna GDS; Brum IS; Branchini G; Pizzolato LS; Capp E; Corleta HVE
Gynecol Endocrinol; 2017 Aug; 33(8):629-633. PubMed ID: 28300476
[TBL] [Abstract][Full Text] [Related]
7. MED12 exon 2 mutations in histopathological uterine leiomyoma variants.
Mäkinen N; Vahteristo P; Kämpjärvi K; Arola J; Bützow R; Aaltonen LA
Eur J Hum Genet; 2013 Nov; 21(11):1300-3. PubMed ID: 23443020
[TBL] [Abstract][Full Text] [Related]
8. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
[TBL] [Abstract][Full Text] [Related]
9. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.
Ono M; Yin P; Navarro A; Moravek MB; Coon JS; Druschitz SA; Serna VA; Qiang W; Brooks DC; Malpani SS; Ma J; Ercan CM; Mittal N; Monsivais D; Dyson MT; Yemelyanov A; Maruyama T; Chakravarti D; Kim JJ; Kurita T; Gottardi CJ; Bulun SE
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17053-8. PubMed ID: 24082114
[TBL] [Abstract][Full Text] [Related]
10. Liposomal 2-Methoxyestradiol Nanoparticles for Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model.
Borahay MA; Vincent KL; Motamedi M; Tekedereli I; Salama SA; Ozpolat B; Kilic GS
Reprod Sci; 2021 Jan; 28(1):271-277. PubMed ID: 32632769
[TBL] [Abstract][Full Text] [Related]
11. The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.
Yang Q; Mas A; Diamond MP; Al-Hendy A
Reprod Sci; 2016 Feb; 23(2):163-75. PubMed ID: 25922306
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas.
Sampath D; Zhu Y; Winneker RC; Zhang Z
J Clin Endocrinol Metab; 2001 Apr; 86(4):1707-15. PubMed ID: 11297607
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.
Matsubara A; Sekine S; Yoshida M; Yoshida A; Taniguchi H; Kushima R; Tsuda H; Kanai Y
Histopathology; 2013 Mar; 62(4):657-61. PubMed ID: 23347103
[TBL] [Abstract][Full Text] [Related]
14. Optimized culture conditions for tissue explants of uterine leiomyoma.
Fiebitz A; Fritsch M; Reichelt U; Ruester C; Chiantera V; Vercellino GF; Darwish A; Schneider A; Mechsner S
Clin Lab; 2012; 58(11-12):1153-64. PubMed ID: 23289184
[TBL] [Abstract][Full Text] [Related]
15. Levonorgestrel inhibits proliferation and induces apoptosis in uterine leiomyoma cells.
Xu Q; Qiu L; Zhu L; Luo L; Xu C
Contraception; 2010 Sep; 82(3):301-8. PubMed ID: 20705162
[TBL] [Abstract][Full Text] [Related]
16. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
[TBL] [Abstract][Full Text] [Related]
17. Growth potential of human uterine leiomyomas: some in vitro observations and their implications.
Cramer SF; Robertson AL; Ziats NP; Pearson OH
Obstet Gynecol; 1985 Jul; 66(1):36-41. PubMed ID: 3892387
[TBL] [Abstract][Full Text] [Related]
18. Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomas.
Machado SA; Bahr JM; Hales DB; Braundmeier AG; Quade BJ; Nowak RA
Biol Reprod; 2012 Oct; 87(4):86. PubMed ID: 22811571
[TBL] [Abstract][Full Text] [Related]
19. Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas.
Moyo MB; Parker JB; Chakravarti D
Nat Commun; 2020 Feb; 11(1):1019. PubMed ID: 32094355
[TBL] [Abstract][Full Text] [Related]
20. FKBP51 Contributes to Uterine Leiomyoma Pathogenesis by Inducing Cell Proliferation and Extracellular Matrix Deposition.
New EP; Semerci N; Ozmen A; Guo X; Jonnalagadda VA; Kim JW; Anderson ML; Guzeloglu-Kayisli O; Imudia AN; Lockwood CJ; Kayisli UA
Reprod Sci; 2022 Jun; 29(6):1939-1949. PubMed ID: 35426036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
